Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viracta Therapeutics Inc (NQ: VIRX )

0.8101 -0.0299 (-3.56%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 58,371
Open 0.8400
Bid (Size) 0.8000 (2)
Ask (Size) 0.9400 (5)
Prev. Close 0.8400
Today's Range 0.8000 - 0.8938
52wk Range 0.4300 - 2.380
Shares Outstanding 38,410,935
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
VIRX Stock Earnings: Viracta Therapeutics Beats EPS for Q1 2024
VIRX stock results show that Viracta Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
3 Speculative Penny Stocks Offering High-Upside Potential for Under a Buck
Although the concept of penny stocks under $1 is wildly speculative, these ideas could fly higher under the right circumstances. 
Via InvestorPlace

Performance

YTD
+38.24%
+38.24%
1 Month
+13.33%
+13.33%
3 Month
+31.06%
+31.06%
6 Month
+41.87%
+41.87%
1 Year
-52.63%
-52.63%

More News

Read More
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Is Small-Cap Cancer Drug Developer Viracta Therapeutics Stock Trading Lower On Monday?
Via Benzinga
Viracta Therapeutics: Q3 Earnings Insights
Via Benzinga
Expert Ratings for Viracta Therapeutics
Via Benzinga
Viracta Therapeutics Says Pivotal Cancer Trial Achieves Efficacy Threshold For Expansion Into Next Stage
Via Benzinga
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
VIRX Stock Earnings: Viracta Therapeutics Misses EPS for Q4 2023
Via InvestorPlace
Analyst Ratings for Viracta Therapeutics
Via Benzinga
Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why Porch Group Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
CACI International To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.